1.Long-term bisphosphonates: primum non nocere

2.Resistance training improves cardiovascular health in postmenopausal women

3.Mechanisms explaining effects of pubertal timing on adulthood cardio-metabolic health

4.Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

5.Anthropometric and cardiovascular responses to hypertrophic resistance training in postmenopausal women

6.Age at menarche, androgen concentrations, and midlife obesity: findings from the Midlife Women's Health Study

7.Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms

8.Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study

9.Timing and persistence of effect of conjugated estrogens/bazedoxifene in postmenopausal women

10.Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trial

11.Measuring hot flash phenomenonology using ambulatory prospective digital diaries

12.Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study

13.In-hospital complications of vaginal versus laparoscopic-assisted benign hysterectomy among older women: a propensity score-matched cohort study

14.Menopause is associated with articular cartilage degeneration: a clinical study of knee joint in 860 women

15.Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome

16.Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial

17.Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women